Evidence from meta-analyses confirmed an excellent diagnostic performance of the serum cystatin C in the diagnosis of DKD, but the advantage of using serum cystatin C over creatinine in the estimates of GFR in diabetes could not be confirmed (54-56). Here, CST3 is linked to diabetic kidney disease.